Limits of traditional evidence-based medicine methodologies exemplified by the novel era in psoriatic arthritis drug development

Emmerik F. Leijten*, Timothy R. Radstake, Iain B. McInnes, Johannes W. Jacobs

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)441-444
Number of pages4
JournalExpert Review of Clinical Immunology
Volume15
Issue number5
DOIs
Publication statusPublished - 4 May 2019

Keywords

  • Biomarker
  • evidence-based medicine
  • psoriatic arthritis
  • trial design

Cite this